Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction

Am J Respir Cell Mol Biol. 2001 Jan;24(1):74-82. doi: 10.1165/ajrcmb.24.1.4125.

Abstract

After parainfluenza type 1 (Sendai) virus infection as weanlings, Brown Norway (BN), unlike Fischer 344 (F344), rats develop an asthma-like phenotype. Reduced postinfection interferon (IFN)-gamma levels in bronchoalveolar lavage fluid from BN weanlings and the prevention of chronic airway sequelae in BN rats by IFN-gamma treatment led to the hypothesis that cells from BN weanlings have a reduced ability to secrete IFN-gamma. After stimulation with Sendai virus or interleukin (IL)-12, splenocytes from uninfected BN weanlings secreted significantly less IFN-gamma than did splenocytes from F344 weanlings (P < 0.005), as determined by enzyme-linked immunosorbent assay. Because levels of potential IFN-gamma-secreting cells in the spleen differed between the strains, natural killer (NK) cells, an important IFN-gamma source during early antiviral responses, were purified from spleens of uninfected weanlings. When stimulated with IL-12, BN NK cells secreted significantly less IFN-gamma than did F344 NK cells (P < 0.001). Incubation of NK cells from either strain with IL-12 and IL-18 resulted in synergistic increases in IFN-gamma production, but BN cells still secreted significantly less IFN-gamma than did F344 cells (P < 0.05). Similarly, after incubation with either IFN-alpha or IFN-alpha plus IL-18, BN NK cells secreted significantly less IFN-gamma than did F344 NK cells (P < 0.05). Therefore, reduced IFN-gamma secretion by NK cells in BN weanlings may play a role in the development of postviral chronic airway dysfunction.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / chemistry
  • Cells, Cultured
  • DNA-Binding Proteins / biosynthesis
  • Disease Susceptibility / immunology
  • Disease Susceptibility / metabolism
  • Interferon-alpha / pharmacology
  • Interferon-gamma / analysis
  • Interferon-gamma / metabolism*
  • Interleukin-12 / analysis
  • Interleukin-12 / metabolism
  • Interleukin-12 / pharmacology
  • Interleukin-18 / pharmacology
  • Janus Kinase 2
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism*
  • Leukocyte Count
  • Lung Diseases, Obstructive / immunology*
  • Lung Diseases, Obstructive / virology
  • Male
  • Phosphorylation
  • Protein Biosynthesis
  • Protein Isoforms / biosynthesis
  • Protein-Tyrosine Kinases / biosynthesis
  • Proto-Oncogene Proteins*
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred F344
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin-12
  • Respirovirus / immunology
  • Respirovirus Infections / immunology*
  • STAT4 Transcription Factor
  • Specific Pathogen-Free Organisms
  • Spleen / cytology
  • Spleen / immunology
  • Spleen / metabolism
  • Spleen / virology
  • T-Lymphocytes / cytology
  • TYK2 Kinase
  • Trans-Activators / biosynthesis

Substances

  • DNA-Binding Proteins
  • Il12rb2 protein, rat
  • Interferon-alpha
  • Interleukin-18
  • Protein Isoforms
  • Proto-Oncogene Proteins
  • Receptors, Interleukin
  • Receptors, Interleukin-12
  • STAT4 Transcription Factor
  • Trans-Activators
  • Interleukin-12
  • Interferon-gamma
  • Protein-Tyrosine Kinases
  • Jak2 protein, rat
  • Janus Kinase 2
  • TYK2 Kinase
  • Tyk2 protein, rat